Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/45873
Full metadata record
DC FieldValueLanguage
dc.contributor.authorvan Wouw, Suzanne A. E.-
dc.contributor.authorLOIX, Melanie-
dc.contributor.authorOttenhoff, Roelof-
dc.contributor.authorKingma, Jenina-
dc.contributor.authorJongejan, Aldo-
dc.contributor.authorBOGIE, Jeroen-
dc.contributor.authorHoekstra, Menno-
dc.contributor.authorZelcer, Noam-
dc.date.accessioned2025-04-17T10:25:54Z-
dc.date.available2025-04-17T10:25:54Z-
dc.date.issued2025-
dc.date.submitted2025-04-11T12:52:20Z-
dc.identifier.citationAtherosclerosis, 403 (Art N° 119163)-
dc.identifier.urihttp://hdl.handle.net/1942/45873-
dc.description.abstractBackground and aims: We recently reported that Endonuclease/Exonuclease/Phosphatase family Domain containing 1 (EEPD1) is a transcriptional target of the sterol-responsive nuclear Liver X Receptors (LXR) in macrophages. The aim of this study is to clarify the in vivo role of EEPD1 in whole-body and macrophage lipid handling, and in the development of atherosclerosis. Methods: We developed mice with global deletion of Eepd1 and challenged them with a high-fat- and a Westerntype diet. Bone marrow-derived macrophages (BMDM) were used for profiling transcriptomic and lipidomic changes, and evaluating cholesterol efflux in the absence of Eepd1. We transplanted bone marrow from wildtype and Eepd1KO mice into LdlrKO recipients to assess the role of myeloid-specific EEPD1 in atherogenesis. Results: Eepd1KO mice were indistinguishable from wildtype controls when fed a low-fat diet. However, when challenged with a high-fat diet or a cholesterol-containing western diet, Eepd1KO displayed enhanced weight gain, with no evident changes in plasma and hepatic lipid levels observed. Consistent with our earlier report, BMDM isolated from Eepd1KO mice had attenuated LXR-stimulated cholesterol efflux to high density lipoprotein and Apolipoprotein A1 when compared to wildtype cells. The transcriptomic and lipidomic landscape of these cells revealed a small reduction in expression of cholesterol biosynthetic genes in LXR-stimulated Eepd1KO cells, and prominent changes in diacylglycerol and hexosylceramides level and species. Changes were also observed in triglyceride and cholesterol-ester species. Myeloid-specific loss of Eepd1 did not alter atherosclerotic plaque size and collagen content in bone marrow-transplanted LdlrKO recipients. Conclusions: Loss of Eepd1 results in an altered lipidomic landscape and reduced LXR-stimulated cholesterol efflux in BMDM, but myeloid-specific loss of Eepd1 does not influence atherogenesis in mice.-
dc.description.sponsorshipFinancial support N.Z. is an Established Investigator of the Dutch Heart Foundation (2013T111) and is supported by a Vici grant from the Netherlands Organization for Scientific Research (NWO; 016.176.643) and an NWO ENW grant (M.22.034; GENESIS). Acknowledgments We thank Ezra van der Wel for help with the atherosclerosis lesion analysis. We also thank Nienke van Loon for her assistance and all members of the Zelcer group, Irith Koster, and Jayron Habibe for their valuable feedback and recommendations. We acknowledge the Core Facility Metabolomics of the AMC (www.cfmetabolomics.nl) for executing the lipidomics analysis.-
dc.language.isoen-
dc.publisherELSEVIER IRELAND LTD-
dc.rights2025 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).-
dc.subject.otherMacrophages-
dc.subject.otherLXR-
dc.subject.otherLipid metabolism-
dc.subject.otherLipidomics-
dc.subject.otherAtherosclerosis-
dc.subject.otherCholesterol metabolism-
dc.titleGlobal deletion of the LXR-regulated gene EEPD1 reveals macrophage-specific changes in lipid metabolism and cholesterol efflux-
dc.typeJournal Contribution-
dc.identifier.volume403-
local.format.pages13-
local.bibliographicCitation.jcatA1-
dc.description.notesZelcer, N (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 15, NL-1105AZ Amsterdam, Netherlands.-
dc.description.notesn.zelcer@amsterdamumc.nl-
local.publisher.placeELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.artnr119163-
dc.identifier.doi10.1016/j.atherosclerosis.2025.119163-
dc.identifier.pmid40121793-
dc.identifier.isi001455492500001-
local.provider.typewosris-
local.description.affiliation[van Wouw, Suzanne A. E.; Ottenhoff, Roelof; Kingma, Jenina; Zelcer, Noam] Univ Amsterdam, Dept Med Biochem, Amsterdam UMC AMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.-
local.description.affiliation[van Wouw, Suzanne A. E.; Ottenhoff, Roelof; Kingma, Jenina; Zelcer, Noam] Amsterdam Inst Gastroenterol Endocrinol & Metab AG, Amsterdam UMC, Amsterdam, Netherlands.-
local.description.affiliation[van Wouw, Suzanne A. E.; Ottenhoff, Roelof; Kingma, Jenina; Zelcer, Noam] Amsterdam Inst Cardiovasc Sci ACS, Amsterdam UMC, Amsterdam, Netherlands.-
local.description.affiliation[Loix, Melanie; Bogie, Jeroen] Hasselt Univ, Biomed Res Inst, Dept Immunol & Infect, Diepenbeek, Belgium.-
local.description.affiliation[Loix, Melanie; Bogie, Jeroen] Univ MS Ctr Hasselt, B-3900 Pelt, Belgium.-
local.description.affiliation[Jongejan, Aldo] Univ Amsterdam, Dept Epidemiol & Data Sci, Bioinformat Lab, Amsterdam UMC AMC, Meibergdreef 9, NL-1105AZ Amsterdam, Netherlands.-
local.description.affiliation[Hoekstra, Menno] Leiden Univ, Leiden Acad Ctr Drug Res LACDR, Div Syst Pharmacol & Pharm, Gorlaeus Labs, Einsteinweg 55, NL-2333CC Leiden, Netherlands.-
local.uhasselt.internationalyes-
item.contributorvan Wouw, Suzanne A. E.-
item.contributorLOIX, Melanie-
item.contributorOttenhoff, Roelof-
item.contributorKingma, Jenina-
item.contributorJongejan, Aldo-
item.contributorBOGIE, Jeroen-
item.contributorHoekstra, Menno-
item.contributorZelcer, Noam-
item.accessRightsOpen Access-
item.fullcitationvan Wouw, Suzanne A. E.; LOIX, Melanie; Ottenhoff, Roelof; Kingma, Jenina; Jongejan, Aldo; BOGIE, Jeroen; Hoekstra, Menno & Zelcer, Noam (2025) Global deletion of the LXR-regulated gene EEPD1 reveals macrophage-specific changes in lipid metabolism and cholesterol efflux. In: Atherosclerosis, 403 (Art N° 119163).-
item.fulltextWith Fulltext-
crisitem.journal.issn0021-9150-
crisitem.journal.eissn1879-1484-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Global .pdfPublished version12.35 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.